PDCD1 and melanoma: Next, the authors integrated bioinformatics into the meta-analysis of five microbiome cohorts of anti-PD-1 therapy in melanoma and reported that the taxa correlated with superior responses mainly were the Actinobacteria phylum and two families of Firmicutes, while those associated with unfavorable responses were mainly Gram-negative bacteria.